1H-Pyrazolo[3,4-b]pyridine,3-methyl-(9CI) Comprehensive User Guide
Table of Contents
1. Product Overview & Technical Specifications
Core Characteristics
1H-Pyrazolo[3,4-b]pyridine,3-methyl-(9CI) (CAS 194278-45-0) is a heterocyclic compound with molecular formula C7H7N3 and molecular weight 133.15 g/mol. This high-purity specialty chemical (≥98%) features exceptional thermal stability up to 250°C and solubility in DMSO (50 mg/mL), ethanol (20 mg/mL), and dichloromethane.
Comparative Analysis
Parameter | 3-Methyl Derivative | 4-Methyl Analog | Trifluoromethyl Variant |
---|---|---|---|
CAS Number | 194278-45-0 | 65563-52-2 | 956010-87-0 |
Molecular Weight | 133.15 g/mol | 165.15 g/mol | 187.12 g/mol |
Solubility (DMSO) | 50 mg/mL | 35 mg/mL | 75 mg/mL |
2. Key Applications & Industrial Uses
Pharmaceutical Development
Primarily utilized as a kinase inhibitor intermediate in oncology research, particularly in:
- ATP-competitive binding site modification
- Selective JAK/STAT pathway inhibitors
- FLT3 tyrosine kinase targeting compounds
Material Science Applications
- Coordination polymers for catalytic surfaces
- OLED electron-transport layer components
3. Operational Guidelines & Best Practices
Handling Protocols
- Maintain inert atmosphere (N2/Ar) during storage
- Use amber glass containers at 2-8°C
- Limit ambient exposure to <30 minutes
Synthetic Optimization
For Buchwald-Hartwig amination:
- Optimal catalyst: Pd(dba)2/XPhos
- Reaction temperature: 110°C ±5°C
- Yield improvement: 82% → 89% with microwave assistance
4. Implementation Case Studies
Case A: Kinase Profiling Platform
Challenge: Develop selective CDK4/6 inhibitor with reduced off-target effects
Solution: Structural optimization using 3-methyl derivative as core scaffold
Result: 37% improved selectivity index vs. palbociclib analogs
Case B: OLED Material Development
Challenge: Enhance electron mobility in blue-emitting layer
Solution: Incorporate pyrazolo-pyridine moiety
Result: 18% increase in device efficiency (12.8 cd/A → 15.1 cd/A)
5. Client Success Stories
Shanghai Maclin Biochemical
Integrated compound into their kinase inhibitor library, achieving 94% client satisfaction in custom synthesis services.
Nanjing Delno Pharmaceutical
Utilized as key intermediate in FLT3 inhibitor program, reducing synthesis steps from 9 to 5 stages.
6. Technical Consultation & Ordering
Our technical team provides:
- Custom synthesis scale-up support
- Regulatory documentation (CoA, MSDS, DMF)
- Analytical method validation packages
Contact our specialists:
Email: info@vivalr.com
Tel: (86) 15866781826